BML Investment Partners, L.P. - 28 May 2025 SCHEDULE 13D/A Report for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: ANTX
Shares outstanding: 30,069,374 shares
Disclosed Ownership: 3,217,423 shares
Ownership: 11%
Form type: SCHEDULE 13D/A
Filing time: 30 May 2025, 17:46:45 UTC
Date of event: 28 May 2025
Previous filing: 07 May 2025
Next filing: 18 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	11%	3,217,423	0	3,217,423	Braden M Leonard	Braden M Leonard - Managing Member of BML Capital Management, LLC	0001373604